vs
Side-by-side financial comparison of AGENUS INC (AGEN) and Clearfield, Inc. (CLFD). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $34.2M, roughly 1.0× AGENUS INC). Clearfield, Inc. runs the higher net margin — -1.8% vs -31.0%, a 29.2% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs -3.2%). Over the past eight quarters, AGENUS INC's revenue compounded faster (10.5% CAGR vs -3.5%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
AGEN vs CLFD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $34.3M |
| Net Profit | $-10.6M | $-614.0K |
| Gross Margin | — | 33.2% |
| Operating Margin | 42.1% | -5.3% |
| Net Margin | -31.0% | -1.8% |
| Revenue YoY | 27.5% | -3.2% |
| Net Profit YoY | 77.3% | 67.8% |
| EPS (diluted) | $0.09 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $34.3M | ||
| Q3 25 | $30.2M | $23.4M | ||
| Q2 25 | $25.7M | $49.9M | ||
| Q1 25 | $24.1M | $47.2M | ||
| Q4 24 | $26.8M | $29.7M | ||
| Q3 24 | $25.1M | $5.6M | ||
| Q2 24 | $23.5M | $48.8M | ||
| Q1 24 | $28.0M | $36.9M |
| Q4 25 | $-10.6M | $-614.0K | ||
| Q3 25 | $63.9M | $-9.1M | ||
| Q2 25 | $-30.0M | $1.6M | ||
| Q1 25 | $-26.4M | $1.3M | ||
| Q4 24 | $-46.8M | $-1.9M | ||
| Q3 24 | $-67.2M | — | ||
| Q2 24 | $-54.8M | $-447.0K | ||
| Q1 24 | $-63.5M | $-5.9M |
| Q4 25 | — | 33.2% | ||
| Q3 25 | 97.9% | 53.2% | ||
| Q2 25 | 99.1% | 30.5% | ||
| Q1 25 | 99.4% | 30.1% | ||
| Q4 24 | 99.6% | 29.2% | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | 21.9% | ||
| Q1 24 | 99.6% | 7.7% |
| Q4 25 | 42.1% | -5.3% | ||
| Q3 25 | -15.0% | 10.3% | ||
| Q2 25 | -65.0% | 3.0% | ||
| Q1 25 | -55.3% | 0.6% | ||
| Q4 24 | -96.5% | -6.9% | ||
| Q3 24 | -125.5% | — | ||
| Q2 24 | -128.4% | -4.7% | ||
| Q1 24 | -117.4% | -26.4% |
| Q4 25 | -31.0% | -1.8% | ||
| Q3 25 | 211.4% | -38.8% | ||
| Q2 25 | -116.8% | 3.2% | ||
| Q1 25 | -109.6% | 2.8% | ||
| Q4 24 | -174.4% | -6.4% | ||
| Q3 24 | -267.7% | — | ||
| Q2 24 | -233.1% | -0.9% | ||
| Q1 24 | -226.6% | -16.0% |
| Q4 25 | $0.09 | $-0.04 | ||
| Q3 25 | $1.94 | $-0.65 | ||
| Q2 25 | $-1.00 | $0.11 | ||
| Q1 25 | $-1.03 | $0.09 | ||
| Q4 24 | $-1.95 | $-0.13 | ||
| Q3 24 | $-3.08 | — | ||
| Q2 24 | $-2.52 | $-0.04 | ||
| Q1 24 | $-3.04 | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $96.4M |
| Total DebtLower is stronger | $44.7M | — |
| Stockholders' EquityBook value | $-271.1M | $249.7M |
| Total Assets | $226.8M | $268.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $96.4M | ||
| Q3 25 | $3.5M | $106.0M | ||
| Q2 25 | $9.5M | $117.2M | ||
| Q1 25 | $18.5M | $112.0M | ||
| Q4 24 | $40.4M | $113.0M | ||
| Q3 24 | $44.8M | $129.0M | ||
| Q2 24 | $93.7M | $123.8M | ||
| Q1 24 | $52.9M | $142.9M |
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $2.1M | ||
| Q1 24 | — | — |
| Q4 25 | $-271.1M | $249.7M | ||
| Q3 25 | $-274.1M | $256.2M | ||
| Q2 25 | $-354.6M | $264.5M | ||
| Q1 25 | $-341.8M | $265.9M | ||
| Q4 24 | $-326.4M | $267.4M | ||
| Q3 24 | $-292.3M | $275.8M | ||
| Q2 24 | $-241.3M | $274.6M | ||
| Q1 24 | $-201.4M | $279.2M |
| Q4 25 | $226.8M | $268.1M | ||
| Q3 25 | $233.9M | $306.2M | ||
| Q2 25 | $185.2M | $314.7M | ||
| Q1 25 | $200.2M | $310.9M | ||
| Q4 24 | $226.3M | $303.2M | ||
| Q3 24 | $238.5M | $315.3M | ||
| Q2 24 | $292.4M | $318.1M | ||
| Q1 24 | $256.6M | $315.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $-1.4M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -7.1% |
| Capex IntensityCapex / Revenue | 0.0% | 2.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $-1.4M | ||
| Q3 25 | $-14.7M | — | ||
| Q2 25 | $-20.2M | $7.9M | ||
| Q1 25 | $-25.6M | $3.0M | ||
| Q4 24 | $-28.7M | $7.2M | ||
| Q3 24 | $-53.3M | $22.2M | ||
| Q2 24 | $-38.2M | $4.0M | ||
| Q1 24 | $-38.2M | $-5.7M |
| Q4 25 | — | $-2.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | $-20.2M | $7.5M | ||
| Q1 25 | $-25.6M | $654.0K | ||
| Q4 24 | $-28.7M | $5.1M | ||
| Q3 24 | $-53.3M | $18.2M | ||
| Q2 24 | $-38.6M | $2.8M | ||
| Q1 24 | $-38.2M | $-7.7M |
| Q4 25 | — | -7.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | -78.7% | 15.1% | ||
| Q1 25 | -106.5% | 1.4% | ||
| Q4 24 | -107.0% | 17.1% | ||
| Q3 24 | -212.2% | 323.0% | ||
| Q2 24 | -164.4% | 5.8% | ||
| Q1 24 | -136.5% | -20.8% |
| Q4 25 | 0.0% | 2.9% | ||
| Q3 25 | 0.0% | 2.0% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.0% | 5.1% | ||
| Q4 24 | 0.3% | 7.0% | ||
| Q3 24 | 0.0% | 71.4% | ||
| Q2 24 | 2.0% | 2.5% | ||
| Q1 24 | 0.1% | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | -0.23× | — | ||
| Q2 25 | — | 4.93× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
CLFD
Segment breakdown not available.
